A Randomized, Double-blinded, Clinical, Placebo-controlled Trial on the Effects of Therapy With Letrozole and hUman Choriongonadotropin in Male Hypogonadism Induced by Illicit Use of Anabolic Androgenic Steroids- The LUCAS Trial

NCT05205837 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Lack of recruitment

Conditions

Hypogonadism
Hypogonadism, Male
Hypogonadotropic Hypogonadism

Interventions

DRUG: Letrozole 2.5mg, hCG
DRUG: Placebo

Sponsor

Rigshospitalet, Denmark